Behçet's syndrome and thrombosis

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 3, Issue 1, 2011, Pages

  Seyahi, Emire ^a   Yurdakul, Sebahattin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857751071     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2011.026     Document Type: Article

References (69)

1. H Behcet. Uber rezidivierende, aphthose, dürch ein Virus verursachte Geshwure am Munde, am Auge und an den Genitalien. Dematologische Wochenschrift 1937;36:1152-1157.
2. Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. New Eng J Med 1999;41:1284-1291. doi:10.1056/NEJM199910213411707 PMid:10528040
3. Yurdakul S, Hamuryudan V, Fresko I, Yazici H. Behçet's syndrome. In Hochberg MC, Silman AJ, Smolen YS, Weinblatt ME, Weisman MH (eds) Rheumatology 5th edn, pp 1575-1581. Philadelphia: Mosby Elsevier, 2011.
4. Direskeneli H, Saruhan-Direskeneli S. Disease Mechanisms. In Yazici Y, Yazici H (eds) Behçet's Syndrome 1th edn, pp 243-264. New York: Springer, 2010.
5. Gul A, Ohno S. Genetics of Behçet's disease. In Yazici Y, Yazici H (eds) Behçet's Syndrome 1th edn, pp 265-276. New York: Springer, 2010.
6. Verity DH, Marr JE, Ohno S et al. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999;54:213-220. doi:10.1034/j.1399-0039.1999.540301.x PMid:10519357
7. Yurdakul S, Yazici Y. Epidemiology of Behçet's syndrome and regional differences in disease expression. In Yazici Y, Yazici H (eds) Behçet's Syndrome 1th edn, pp 35-52. New York: Springer, 2010.
8. Yurdakul S, Tuzuner N, Yurdakul I et al. Gastrointestinal involvement in Behçet's syndrome: a controlled study. Ann Rheum Dis 1996;55:208-210 doi:10.1136/ard.55.3.208 PMid:8712889 PMCid:1010133
9. Yazici H, Chamberlain MA, Tuzun Y et al. A comparative study of the pathergy among Turkish and British patients with Behçet's disease. Ann Rheum Dis 1984;43:74-75. PMid:6696522 PMCid:1001226
10. Yazici H, Tuzun Y, Pazarli H et al. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 1984;43:783-789. doi:10.1136/ard.43.6.783 PMid:6524980 PMCid:1001536
11. Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003; 82:60-76. doi:10.1097/00005792-200301000-00006 PMid:12544711
12. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-1080. PMid:1970380
13. Mat C, Göksugur N, Engin B et al. The frequency of scarring after genital ulcers in Behçet's syndrome: a prospective study. Int J Dermatol 2006;45:554-556. doi:10.1111/j.1365-4632.2006.02859.x PMid:16700790
14. Ergun T, Gurbuz O, Dogusoy G et al. Histopathologic features of the spontaneous pustular lesions of Behçet's syndrome. Int J Dermatol 1998;37:194-196. PMid:9556106
15. Tüzün Y, Yazici H, Pazarli H et al. The usefulness of the nonspecific skin hyperreactivity (The pathergy test) in Behçet's disease in Turkey. Acta Dermatovener (Stockholm) 1979;59:77-79.
16. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R et al. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 2004;138:373-380. doi:10.1016/j.ajo.2004.03.022 PMid:15364218
17. Yurdakul S, Yazici H, Tuzun Y et al. The arthritis of Behçet's disease: a prospective study. Ann Rheum Dis 1983;42:505-515. doi:10.1136/ard.42.5.505 PMid:6625699 PMCid:1001284
18. Yazici H, Tuzlaci M, Yurdakul S. A controlled survey of sacroiliitis in Behçet's disease. Ann Rheum Dis 1981;40:558-559. doi:10.1136/ard.40.6.558 PMid:7332375 PMCid:1000829
19. Diri E, Mat C, Hamuryudan V et al. Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis 2001;60:1074-1076. doi:10.1136/ard.60.11.1074 PMid:11602484 PMCid:1753421
20. Hatemi G, Fresko I, Tascilar K, Yazici H. Enthesopathy is increased among Behçet's syndrome patients with acne and arthritis: an ultrasonographic study. Arthritis Rheum 2008; 58:1539-1545. doi:10.1002/art.23450
21. Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 1999;122:2171-2182. doi:10.1093/brain/122.11.2171 PMid:10545401
22. Siva A, Kantarci OH, Saip S et al. Behçet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurology 2001;248:95-103. doi:10.1007/s004150170242 PMid:11284141
23. Shimizu T, Ehrlich GE, Inaba G, Hayashi K. Behçet disease (Behçet syndrome). Semin Arthritis Rheum 1979;8:223-260. doi:10.1016/0049-0172(79)90004-0
24. Korman U, Cantasdemir M, Kurugoglu S et al. Enteroclysis findings of intestinal Behcet disease: a comparative study with Crohn disease. Abdom Imaging 2003;28:308-312. doi:10.1007/s00261-002-0036-0 PMid:12719899
25. Bayraktar Y, Ozaslan E, Van Thiel DH. Gastrointestinal manifestations of Behcet's disease. J Clin Gastroenterol 2000;30:144-154. doi:10.1097/00004836-200003000-00006 PMid:10730919
26. Melikoglu M, Ugurlu S, Tascilar K. et al. Large Vessel Involvement in Behcet's Syndrome: A Retrospective Survey. Ann Rheum Dis. 2008;67(Suppl II):67.
27. Hamza M. Large artery involvement in Behcet's disease. J Rheumatol. 14: 554-9, 1987. PMid:3625635
28. Bayraktar Y, Balkanci F, Bayraktar M, et al. Budd-Chiari syndrome: a common complication of Behçet's disease. Am J Gastroenterol. 1997;92:858-62. PMid:9149201
29. Seyahi E, Ozdogan H, Ugurlu S et al. The outcome children with Behçet's syndrome. Clin Exp Rheumatol 2004, 22: Suppl 34: 116.
30. Koc Y, Gullu I, Akpek G, et al. Vascular involvement in Behcet's disease. J Rheumatol 1992, 19: 402-10. PMid:1578454
31. Tohmé A, Aoun N, El-Rassi B, et al. Vascular manifestations of Behçet's disease. Eighteen cases among 140 patients. Joint Bone Spine. 2003;70:384-9. PMid:14563470
32. Sarica-Kucukoglu R, Akdag-Kose A, Kayabali M, et al. Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases. Int J Dermatol. 2006;45:919-21. doi:10.1111/j.1365-4632.2006.02832.x PMid:16911374
33. Düzgün N, Ates A, Aydintug OT, et al. Characteristics of vascular involvement in Behçet's disease. Scand J Rheumatol. 2006;35:65-8. PMid:16467046
34. Chae EJ, Do KH, Seo JB, et al. Radiologic and clinical findings of Behçet disease: comprehensive review of multisystemic involvement. Radiographics. 2008t;28(5):e31. doi:10.1148/rg.e31 PMid:18603663
35. Cakmak OS, Seyahi E, Kantarci F et al. Venous severity assessment in Behçet's syndrome. Clin Exp Rheumatol 2010, 28: Suppl 60: S-139.
36. Ugurlu S, Seyahi E, Yazici H. Prevalence of angina, myocardial infarction and intermittent claudication assessed by Rose Questionnaire among patients with Behcet's syndrome. Rheumatology 2008; 47: 472-5. doi:10.1093/rheumatology/kem385 PMid:18270223
37. Walker RT, Woodyer AB, Dormandy JA. Venous claudication. A report of 15 cases and a review of the literature. Int Angiol 1985; 4: 365-7. PMid:3831158
38. Seyahi E, Memisoglu E, Hamuryudan V et al. Coronary atherosclerosis in Behcet's syndrome: a pilot study using electron-beam computed tomography. Rheumatology (Oxford). 2004; 43: 1448-50. doi:10.1093/rheumatology/keh359 PMid:15501997
39. Seyahi E, Ugurlu S, Cumali R, et al. Atherosclerosis in Behçet's Syndrome. Semin Arthritis Rheum. 2008; 38:1-12. doi:10.1016/j.semarthrit.2007.09.009 PMid:18221989
40. Rhee MY, Chang HK, Kim SK. Intima-media thickness and arterial stiffness of carotid artery in Korean patients with Behçet's disease. J Korean Med Sci. 2007; 22:387-92. doi:10.3346/jkms.2007.22.3.387 PMid:17596642 PMCid:2693626
41. Tunc R, Keyman E, Melikoglu M, Fresko I, Yazici H. Target organ associations in Turkish patients with Behçet's disease: a cross sectional study by exploratory factor analysis. J Rheumatol. 2002;29:2393-6. PMid:12415598
42. Yazici H. The lumps and bumps of Behcet's syndrome. Autoimmun Rev 2004; Suppl 1:S53-4. PMid:15309796
43. Demirkesen C, Tuzuner N, Mat C et al. Clinicopathologic evaluation of nodular cutaneous lesions of Behcet syndrome. Am J Clin Pathol 2001; 116: 341-6. doi:10.1309/GCTH-0060-55K8-XCTT PMid:11554161
44. Hamuryudan V, Melikoglu M. Vascular involvement in Behçet's syndrome. In Yazici Y, Yazici H (eds) Behçet's Syndrome 1th edn, pp115-134. New York: Springer, 2010.
45. Tunc R, Saip S, Siva A, Yazici H. Cerebral venous thrombosis is associated with major vessel disease in BS's syndrome. Ann Rheum Dis. 2004;63:1693-4. doi:10.1136/ard.2003.018515 PMid:15547099 PMCid:1754854
46. Hamuryudan V, Yurdakul S, Moral F, et al. Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases. Br J Rheumatol. 1994; 33: 48-51. doi:10.1093/rheumatology/33.1.48
47. Hamuryudan V, Er T, Seyahi E, et al. Pulmonary artery aneurysms in Behcet syndrome. Am J Med. 2004; 117: 867-70. doi:10.1016/j.amjmed.2004.05.027 PMid:15589493
48. Seyahi E, Melikoglu M, Akman C et al. Pulmonary vascular involvement in Behcet's syndrome. Arthritis Rheum. 2007;56 (Suppl 9):S357.
49. Lakhanpal S, Tani K, Lie JT, et al. Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. Hum Pathol. 1985;16:790-5. doi:10.1016/S0046-8177(85)80250-1
50. Tüzün H, Besirli K, Sayin A, et al. Yazici H. Management of aneurysms in Behçet's syndrome: an analysis of 24 patients. Surgery. 1997;121:150-6. doi:10.1016/S0039-6060(97)90284-1
51. Mogulkoc N, Burgess MI, Bishop PW. Intracardiac thrombus in Behçet's disease: a systematic review. Chest. 2000;118:479-87. doi:10.1378/chest.118.2.479 PMid:10936144
52. Fresko I, Melikoglu M, Tunc R et al. Behcet's syndrome: pathogenesis, clinical manifestations and treatment in Vasculitis by Gene V. Ball, S. Louis Bridges ed. Oxford University Press, USA; 1st edition (2002).
53. Demirkesen C, Oz B, Goksel S. Histopathology of Behcet's syndrome. In Yazici Y, Yazici H (eds) Behçet's Syndrome 1th edn, pp215-242. New York: Springer, 2010.
54. Kobayashi M, Ito M, Nakagawa A, et al. Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease. Histopathology. 2000;36:362-71. doi:10.1046/j.1365-2559.2000.00859.x PMid:10759951
55. Sengül N, Demirer S, Yerdel MA, et al. Comparison of coagulation parameters for healthy subjects and Behçet disease patients with and without vascular involvement. World J Surg. 2000;24:1584-8. doi:10.1007/s002680010282
56. Espinosa G, Font J, Tassies D, et al. Vascular involvement in Behcet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. American Journal of Medicine. 2002; 112:37-43. doi:10.1016/S0002-9343(01)01048-8
57. Leiba M, Seligsohn U, Sidi Y, et al. Thrombophilic factors are not the leading cause of thrombosis in Behcet's disease. Annals of the Rheumatic Diseases, 2004;63:1445-9. doi:10.1136/ard.2003.014241 PMid:15479893 PMCid:1754810
58. Lee YJ, Kang SW, Yang JI, et al. Coagulation parameters and plasma total homocysteine levels in Behcet's disease. Thromb Res. 2002;106:19-24. doi:10.1016/S0049-3848(02)00085-3
59. Mader R, Ziv M, Adawi M, et al. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease. J Rheumatol. 1999;26:2404-8 PMid:10555901
60. Yurdakul S, Hekim N, Soysal T, et al. Fibrinolytic activity and d-dimer levels in Behçet's syndrome. Clin Exp Rheumatol. 2005;23(4 Suppl 38):S53-8.
61. Ricart JM, Ramón LA, Vayá A, et al. Fibrinolytic inhibitor levels and polymorphisms in Behçet disease and their association with thrombosis. Br J Haematol. 2008;141:716-9. doi:10.1111/j.1365-2141.2008.07078.x PMid:18341631
62. Gül A, Özbek U, Öztürk C, Inanç M, Koniçe M, Ozçelik T. Coagulation factor V gene mutation increases the risk of venous thrombosis in Behçet's disease. Br J Rheumatol 1996;35:1178-80 PMid:8948311
63. Toydemir PB, Elhan AH, Tükün A, et al. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease. J Rheumatol. 2000;27:2849-54 PMid:11128675
64. Silingardi M, Salvarani C, Boiardi L, et al. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Rheum. 2004;51:177-83. doi:10.1002/art.20237
65. Kahraman O, Celebi-Onder S, Kamali S et al. Long-term course of deep venous thrombosis in Patients with Behçet's disease. Arthritis Rheum 2003; 48 (Suppl 9): S385
66. Ahn JK, Lee YS, Jeon CH, et al. Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol. 2008;27:201-5. doi:10.1007/s10067-007-0685-z PMid:17636362
67. Yazici H, Pazarli H, Barnes CG, et al. A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med 1990; 322: 281-5. doi:10.1056/NEJM199002013220501 PMid:2404204
68. Hamuryudan V, Ozyazgan Y, Hizli N, et al. Azathioprine in Behcet's syndrome: effects on long-term prognosis. Arthritis Rheum 1997; 40: 769-74. doi:10.1002/art.1780400425
69. Hatemi G, Silman A, Bang D, et al. Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis. 2009;68:1528-34. doi:10.1136/ard.2008.087957 PMid:18420940